| Patient | Arthur Ashe |
|---|---|
| Date of birth | 1980-07-10 |
| Identifiers | MRN HR-ML013-SYN; SSN (made up) 000-13-6620 |
| Document date | 2026-01-12 |
| Author | Vivian Tolliver, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Establishing primary care for HIV after a recent diagnosis with cerebral toxoplasmosis, and for coronary artery disease after two bypass operations [S]
This fictional modern episode addresses the presenting concerns below. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
2 later historical claims are omitted because they describe events after the index age. See the teaching note.
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| July 31, 1979 | Heart attack at age 36 while teaching tennis to young people, followed by quadruple coronary artery bypass surgery | D (CLM-0002) |
| 1983 | Second (double) bypass operation for recurrent chest pain, with a blood transfusion | D (CLM-0003) |
| 1988 | Right-arm weakness from a left-sided brain mass, removed and found to be toxoplasmosis; HIV and AIDS diagnosed, believed to have been acquired from the transfusion during the 1983 operation | D (CLM-0004, CLM-0005) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| mother | Died at 27 of complications from surgery; atherosclerotic heart disease at an early age reported | D (CLM-0007) | |
| father | Heart attacks at 55 and 59; atherosclerotic heart disease at an early age reported | D (CLM-0007) |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesium | One tablet by mouth once daily | Oral route | 2025-09-25 | active | S |
| Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intake | Three tablets by mouth daily after a 200 mg loading dose | Oral route | 2025-09-11 to 2025-10-23 | completed | S |
| Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intake | Three tablets by mouth every 6 hours | Oral route | 2025-09-11 to 2025-10-23 | completed | S |
| Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intake | Two tablets by mouth daily | Oral route | 2025-09-11 to 2025-10-23 | completed | S |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice daily | One tablet by mouth twice daily | Oral route | 2025-10-23 to 2026-10-19 | completed | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2016-07-31 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2016-08-01 | active | S |
| Ezetimibe 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-01-12 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tablet | One tablet under the tongue every 5 minutes as needed for chest pain, up to 3 doses | Sublingual route | 2016-08-01 | active | S |
Positive for the concerns in the history of present illness. Alert, composed, and thoughtful; asks precise questions about his treatment. Mood mostly good, with worry about his family and his privacy; PHQ-9 score 5 with item 9 scored 0; no thoughts of self-harm. No other systems reported as affected in this synthetic episode. [S]
Alert and engaged. Right-hand weakness at diagnosis has recovered: grip and fine finger movements equal on both sides; writes and plays without difficulty. Independent in all activities; vigorous exercise without angina or breathlessness. [S]
Vital signs recorded on 2026-01-12; see the Vital Signs section. Mental status: Alert, composed, and thoughtful; asks precise questions about his treatment; Mood mostly good, with worry about his family and his privacy; PHQ-9 score 5 with item 9 scored 0; no thoughts of self-harm. The physical examination is limited to the findings relevant to this synthetic episode. [S]
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-12 | Body height | 185 | cm | S |
| 2026-01-12 | Body weight | 72 | kg | S |
| 2026-01-12 | Body mass index (BMI) [Ratio] | 21 | kg/m2 | S |
| 2026-01-12 | Systolic blood pressure | 118 | mm[Hg] | S |
| 2026-01-12 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-01-12 | Heart rate | 72 | /min | S |
| 2026-01-12 | Respiratory rate | 14 | /min | S |
| 2026-01-12 | Body temperature | 36.7 | Cel | S |
| 2026-01-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-12 | HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection | 42 | {copies}/mL | Below 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detected | High | S |
| 2026-01-12 | CD3+CD4+ (T4 helper) cells [#/volume] in Blood | 156 | /uL | 500-1500 /uL | Low | S |
| 2026-01-12 | Leukocytes [#/volume] in Blood by Automated count | 4.2 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-01-12 | Hemoglobin [Mass/volume] in Blood | 13 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-01-12 | Platelets [#/volume] in Blood by Automated count | 198 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-01-12 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-01-12 | Potassium [Moles/volume] in Serum or Plasma | 4.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-01-12 | Creatinine [Mass/volume] in Serum or Plasma | 1.18 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-01-12 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 78 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-01-12 | Glucose [Mass/volume] in Serum or Plasma | 92 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-01-12 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 30 | U/L | 7-56 U/L | Normal | S |
| 2026-01-12 | Cholesterol [Mass/volume] in Serum or Plasma | 158 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-01-12 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 40 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-01-12 | Triglyceride [Mass/volume] in Serum or Plasma | 150 | mg/dL | <=149 mg/dL | High | S |
| 2026-01-12 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 88 | mg/dL | <=99 mg/dL | Normal | S |
| 2026-01-12 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.4 | % | <=5.6% | Normal | S |
| 2026-01-12 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 2026-01-12 | Total score [AUDIT-C] | 1 | {score} | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infection | active | confirmed | B20 | S — Synthetic modern coding of the documented HIV infection and AIDS diagnosis; B20 stays the code after an AIDS-defining illness, however well the infection is controlled. |
| Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapy | active | confirmed | B58.2 | S — Synthetic modern coding of the documented 1988 toxoplasmosis; the modern diagnosis was by biopsy rather than removal of the mass. |
| Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1979 and 1983 operations | active | confirmed | I25.10 | S — Synthetic modern diagnosis; the history remains D. |
| Old myocardial infarction at age 36 | active | confirmed | I25.2 | S — Synthetic coded history of the documented 1979 heart attack. |
| Hyperlipidemia, on high-intensity statin | active | confirmed | E78.5 | S — Synthetic diagnosis; no cholesterol value from his lifetime is used. |